|
Synonyms: ABBV-101 | Compound 1 [US20240109877]
Compound class:
Synthetic organic
Comment: Omtebrutideg is the INN for a Bruton tyrosine kinase PROTAC degrader. It is proposed for antineoplastic effects. The structure indicates that it is designed to engage the cereblon (CRBN) E3 ubiquitin ligase. Available evidence suggests that omtebrutideg is likely the INN for Abbvie's lead BTK PROTAC ABBV-101 [2-3]. Targeted protein degradation is intended as a strategy to overcome BTK inhibitor resistance in B cell malignancies.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Omtebrutideg has a DC50 of 4.1 nM for BTK protein and a Dmax of 100% in human human whole blood [1]. |
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||